Pay in 4 interest-free payments of $5.37 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
No UK Summary of Product Characteristics (SmPC) or European Public Assessment Report (EPAR) currently exists for this medicine
Doses were titrated until a fasting glycemia between 80100 mg/dL was achieved
In the trial, 6.5% of participants taking Wegovy had a major adverse cardiovascular event compared to 8% on placebo, according to the FDA
Please note: researchers must use this peptide only for lab work
US$ 23.35
US$ 22.14
US$ 27.23
US$ 21.33
US$ 22.74
